Citation: R. Kronenwett et R. Haas, ANTISENSE STRATEGIES FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS, Annals of hematology, 77(1-2), 1998, pp. 1-12
Authors:
KRONENWETT R
STEIDL U
KIRSCH M
SCZAKIEL G
HAAS R
Citation: R. Kronenwett et al., OLIGODEOXYRIBONUCLEOTIDE UPTAKE IN PRIMARY HUMAN HEMATOPOIETIC-CELLS IS ENHANCED BY CATIONIC LIPIDS AND DEPENDS ON THE HEMATOPOIETIC-CELL SUBSET, Blood, 91(3), 1998, pp. 852-862
Authors:
PATZEL V
KRONENWETT R
RITTNER K
SCZAKIEL G
Citation: V. Patzel et al., FAST RNA-RNA ANNEALING IN-VITRO - SINGLE-CYCLE SELECTION VERSUS MULTIPLE CYCLE SELECTION, Nucleosides & nucleotides, 16(5-6), 1997, pp. 711-715
Citation: R. Kronenwett et al., ENHANCEMENT OF OLIGONUCLEOTIDE UPTAKE INTO DIFFERENT PRIMARY HEMATOPOIETIC-CELL SUBSETS BY CANONIC LIPIDS, Experimental hematology, 25(8), 1997, pp. 578-578
Authors:
VIARDOT A
KRONENWETT R
DEICHMANN M
HAAS R
Citation: A. Viardot et al., THE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-TYPE-1 CORECEPTOR CXCR-4 (FUSIN, LESTR) IS PREFERENTIALLY EXPRESSED ON THE MORE IMMATURE CD34(-CELLS() HEMATOPOIETIC STEM), Blood, 90(10), 1997, pp. 2126-2126
Citation: M. Deichmann et al., EXPRESSION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CORECEPTORS CXCR-4 (FUSIN, LESTR) AND CKR-5 IN CD34(+) HEMATOPOIETIC PROGENITOR CELLS, Blood, 89(10), 1997, pp. 3522-3528
Citation: R. Haas et al., THE TELOMERE LENGTH OF BLOOD-DERIVED MONONUCLEAR-CELLS FROM CANCER-PATIENTS DURING G-CSF-ENHANCED MARROW RECOVERY CORRELATES WITH AGE BUT IS NOT RELATED TO THE CD34-CELL YIELD AND PREVIOUS CYTOTOXIC THERAPY( STEM), Experimental hematology, 24(9), 1996, pp. 105-105
Citation: R. Kronenwett et al., IN-VITRO SELECTION AND DELIVERY OF SPECIFICALLY HYBRIDIZING BCR-ABL-DIRECTED ANTISENSE NUCLEIC-ACIDS AND RIBOZYMES, Experimental hematology, 24(9), 1996, pp. 166-166
Citation: R. Kronenwett et al., KINETIC SELECTIVITY OF COMPLEMENTARY NUCLEIC-ACIDS - BCR-ABL-DIRECTEDANTISENSE RNA AND RIBOZYMES, Journal of Molecular Biology, 259(4), 1996, pp. 632-644